Antipsychotic-like actions of the satiety peptide, amylin, in ventral striatal regions marked by overlapping calcitonin receptor and RAMP-1 gene expression

Journal of Neuroscience

Volumn 34, Issue 12, 2014, Pages 4318-4325

  Baisley, Sarah K ^a   Bremer, Quentin Z ^b   Bakshi, Vaishali P ^a,b   Baldo, Brian A ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Amylin receptor; Dopamine; Nucleus accumbens; RAMPs; Schizophrenia; Startle

Indexed keywords

AMYLIN; CALCITONIN RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SATIETY;

AMYLIN RECEPTOR; DOPAMINE; NUCLEUS ACCUMBENS; RAMPS; SCHIZOPHRENIA; STARTLE;

AMPHETAMINE; ANIMALS; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA; DOPAMINE AGENTS; GENE EXPRESSION; ISLET AMYLOID POLYPEPTIDE; PEPTIDE FRAGMENTS; RATS; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RECEPTORS, CALCITONIN; SENSORY GATING; STARTLE REACTION;

EID: 84896286626     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2260-13.2014     Document Type: Article

References (50)

1. Aiyar N, Baker E, Martin J, Patel A, Stadel JM, Willette RN, Barone FC (1995) Differential calcitonin gene-related peptide (CGRP) and amylin binding sites in nucleus accumbens and lung: potential models for studying CGRP/amylin receptor subtypes. J Neurochem 65: 1131-1138. Medline.
2. Alsene KM, Fallace K, Bakshi VP (2010) Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine. Neuropsychopharmacology 35: 2346-2356. CrossRef Medline.
3. Alsene KM, Rajbhandari AK, Ramaker MJ, Bakshi VP (2011) Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating. Neuropsychopharmacology 36: 1003-1014. CrossRef Medline.
4. Arnelo U, Reidelberger R, Adrian TE, Larsson J, Permert J (1998) Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats. Am J Physiol 275: R1537-R1542. Medline.
5. Baldo BA, Kelley AE (2001) Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior. Am J Physiol Regul Integr Comp Physiol 281: R1232-R1242. Medline.
6. Banks WA, Kastin AJ (1998) Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 19: 883-889. CrossRef Medline.
7. Beaumont K, Kenney MA, Young AA, Rink TJ (1993) High affinity amylin binding sites in rat brain. Mol Pharmacol 44: 493-497. Medline.
8. Becskei C, Riediger T, Zünd D, Wookey P, Lutz TA (2004) Immunohistochemical mapping of calcitonin receptors in the adult rat brain. Brain Res 1030: 221-233. CrossRef Medline.
9. Benoit SC, McQuade JA, Clegg DJ, Xu M, Rushing PA, Woods SC, Seeley RJ (2003) Altered feeding responses in mice with targeted disruption of the dopamine-3 receptor gene. Behav Neurosci 117: 46-54. CrossRef Medline.
10. Boyd KN, Mailman RB (2012) Dopamine receptor signaling and current and future antipsychotic drugs. Handb Exp Pharmacol 53-86. CrossRef Medline.
11. Braff DL, Light GA (2004) Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology 174: 75-85. Medline.
12. Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA (1990) Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752-756. CrossRef Medline.
13. Castillo MJ, Scheen AJ, Lefèbvre PJ (1995) Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology. Diabete Metab 21: 3-25. Medline.
14. Christopoulos G, Paxinos G, Huang XF, Beaumont K, Toga AW, Sexton PM (1995) Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain. Can J Physiol Pharmacol 73: 1037-1041. CrossRef Medline.
15. Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, Main MJ, Foord SM, Sexton PM (1999) Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56: 235-242. Medline.
16. Clementi G, Valerio C, Emmi I, Prato A, Drago F (1996) Behavioral effects of amylin injected intracerebroventricularly in the rat. Peptides 17: 589-591. CrossRef Medline.
17. Clementi G, Busa L, de Bernardis E, Prato A, Drago F (1999) Effects of centrally injected amylin on sexually behavior of male rats. Peptides 20: 379-382. CrossRef Medline.
18. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU (2012) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8: 114-126. CrossRef Medline.
19. Geyer MA (2006) Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia? Dialogues Clin Neurosci 8: 9-16. Medline.
20. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25: 485-498. CrossRef Medline.
21. Hay DL, Christopoulos G, Christopoulos A, Poyner DR, Sexton PM (2005) Pharmacological discrimination of calcitonin receptor: receptor activitymodifying protein complexes. Mol Pharmacol 67: 1655-1665. CrossRef Medline.
22. Lee J, Gomez-Ramirez J, Johnston TH, Visanji N, Brotchie JM (2008) Receptoractivity modifying protein 1 expression is increased in the striatum following repeatedL-DOPAadministration in a6-hydroxydopaminelesioned ratmodelof Parkinson's disease. Synapse 62: 310-313. CrossRef Medline.
23. Lutz TA (2012) Control of energy homeostasis by amylin. Cell Mol Life Sci 69: 1947-1965. CrossRef Medline.
24. Lutz TA, Del Prete E, Szabady MM, Scharrer E (1995) Circadian anorectic effects of peripherally administered amylin in rats. Z Ernahrungswiss 34: 214-219. CrossRef Medline.
25. Lutz TA, Tschudy S, Mollet A, Geary N, Scharrer E (2001) Dopamine D(2) receptors mediate amylin's acute satiety effect. Am J Physiol Regul Integr Comp Physiol 280: R1697-R1703. Medline.
26. Mietlicki-Baase EG, Rupprecht LE, Olivos DR, Zimmer DJ, Alter MD, Pierce RC, Schmidt HD, Hayes MR (2013) Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake. Neuropsychopharmacology 38: 1685-1697. CrossRef Medline.
27. Moore CX, Cooper GJ (1991) Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents. Biochem Biophys Res Commun 179: 1-9. CrossRef Medline.
28. Nakamoto H, Soeda Y, Takami S, Minami M, Satoh M (2000) Localization of calcitonin receptor mRNA in the mouse brain: coexistence with serotonin transporter mRNA. Brain Res Mol Brain Res 76: 93-102. CrossRef Medline.
29. Ogawa A, Harris V, McCorkle SK, Unger RH, Luskey KL (1990) Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment. J Clin Invest 85: 973-976. CrossRef Medline.
30. Oliver KR, Kane SA, Salvatore CA, Mallee JJ, Kinsey AM, Koblan KS, Keyvan-Fouladi N, Heavens RP, Wainwright A, Jacobson M, Dickerson IM, Hill RG (2001) Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur J Neurosci 14: 618-628. CrossRef Medline.
31. Peciña S, Berridge KC (2005) Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness? J Neurosci 25: 11777-11786. CrossRef Medline.
32. Potes CS, Lutz TA, Riediger T (2010) Identification of central projections from amylin-activated neurons to the lateral hypothalamus. Brain Res 1334: 31-44. CrossRef Medline.
33. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233-246. CrossRef Medline.
34. Qi D, Cai K, Wang O, Li Z, Chen J, Deng B, Qian L, Le Y (2010) Fatty acids induce amylin expression and secretion by pancreatic beta-cells. Am J Physiol Endocrinol Metab 298: E99-E107. CrossRef Medline.
35. Roth JD, Roland BL, Cole RL, Trevaskis JL, Weyer C, Koda JE, Anderson CM, Parkes DG, Baron AD (2008) Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci U S A 105: 7257-7262. CrossRef Medline.
36. Roth JD, Maier H, Chen S, Roland BL (2009) Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications. Arch Neurol 66: 306-310. CrossRef Medline.
37. Roth JD, Erickson MR, Chen S, Parkes DG (2012) GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities. Br J Pharmacol 166: 121-136. CrossRef Medline.
38. Rushing PA, Hagan MM, Seeley RJ, Lutz TA, D'Alessio DA, Air EL, Woods SC (2001) Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 142: 5035. CrossRef Medline.
39. Schochet TL, Bremer QZ, Brownfield MS, Kelley AE, Landry CF (2008) The dendritically targeted protein Dendrin is induced by acute nicotine in cortical regions of adolescent rat brain. Eur J Neurosci 28: 1967-1979. CrossRef Medline.
40. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K (1994) In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 62: 553-567. CrossRef Medline.
41. Sexton PM, Morfis M, Tilakaratne N, Hay DL, Udawela M, Christopoulos G, Christopoulos A (2006) Complexing receptor pharmacology: modulation of family BGprotein-coupled receptor function by RAMPs. AnnN Y Acad Sci 1070: 90-104. CrossRef Medline.
42. Singh-Franco D, Perez A, Harrington C (2011) The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 13: 169-180. CrossRef Medline.
43. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL (2008) Realistic expecta-tions of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology 199: 331-388. CrossRef Medline.
44. Turek VF, Trevaskis JL, Levin BE, Dunn-Meynell AA, Irani B, Gu G, Wittmer C, Griffin PS, Vu C, Parkes DG, Roth JD (2010) Mechanisms of amylin/leptin synergy in rodent models. Endocrinology 151: 143-152. CrossRef Medline.
45. Ueda T, Ugawa S, Saishin Y, Shimada S (2001) Expression of receptoractivity modifying protein (RAMP)mRNAsin the mouse brain. Brain Res Mol Brain Res 93: 36-45. CrossRef Medline.
46. van Rossum D, Ménard DP, Fournier A, St-Pierre S, Quirion R (1994) Autoradiographic distribution and receptor binding profile of [125I]Bolton Hunter-rat amylin binding sites in the rat brain. J Pharmacol Exp Ther 270: 779-787. Medline.
47. van Rossum D, Hanisch UK, Quirion R (1997) Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 21: 649-678. CrossRef Medline.
48. Young A (2005) Receptor pharmacology. Adv Pharmacol 52: 47-65. CrossRef Medline.
49. Young A, DenaroM (1998) Roles of amylin in diabetes and in regulation of nutrient load. Nutrition 14: 524-527. CrossRef Medline.
50. Zahm DS, Heimer L (1993) Specificity in the efferent projections of the nucleus accumbens in the rat: comparison of the rostral pole projection patterns with those of the core and shell. J Comp Neurol 327: 220-232. CrossRef Medline.